[1]
“Long-term treatment with anakinra and canakinumab resolves patellar subchondral erosion in neonatal-onset multisystem inflammatory disease”, Reumatismo, vol. 71, no. 1, pp. 53–55, Apr. 2019, doi: 10.4081/reumatismo.2019.1142.